Once biopsy and scan results are known and there is a diagnosis os localised prostate cancer, all results will be reviewed at a special meeting called a Multi-Disciplinary Team Meeting (MDT). This is made up of urologists, oncologists (cancer specialists), radiologists (x-ray specialists), pathologists (tissue specialists) and specialist nurses.
The MDT will recommend treatment options based on the clinical stage of the cancer. The specialist team will then discuss these treatment options with you. The MDT’s recommendations will be based on the team’s clinical experience and national guidelines.
Prostate cancer treatment in the UK uses guidelines set down by The National Institute for Health and Care Excellence (NICE). NICE has classified prostate cancer into low, medium and high risk groups. Your group assignment will be based on your PSA blood tests from your initial diagnosis, your Gleason score and your clinical stage:
| NICE Risk Level | PSA Blood Test Results | Gleason Score | Clinical Stage |
|---|---|---|---|
| Low | Less than 10 | Less than or equal to 6 | T1-T2a |
| Intermediate | 10-20 | 7 | T2b-T2c |
| High | Above 20 | 8-10 | T3-T4 |
A full summary of NICE guidelines is here.
Men should meet or be given the details of a Clinical Nurse Specialist (CNS). The CNS will be able to provide information and support about possible treatment options. They will also act as a keyworker and point of contact during treatment.
Men may find it helpful to join a prostate cancer support group where they can meet other men in a similar situation. Here is a list of prostate cancer support groups.
Most cases of localised prostate cancer are low or medium grade cancer and categorised as clinical stage T1 or T2. There are several possible treatments that could lead to a potential cure. These include surgery or radiotherapy
Some treatments may not be suitable due to an inappropriate PSA level, size of the prostate gland or other health conditions.
There are several types of treatment for localised prostate cancer, all with a similar success rate and potential side effects.
Our support team at Orchid is on hand to help men discuss options.
